1	impact	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	0	_	_	_	_	_	of.prep	Age	O
3	stalin	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
4	adherence	_	Adherence	_	NNP	0	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	0	_	_	_	_	_	_	_	O
6	cardiovascular	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
7	morbidity	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
9	all-cause	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O

1	impact	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
2	of	_	of	_	IN	0	_	_	_	_	_	_	_	O
3	stalin	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
4	adherence	_	Adherence	_	NNP	0	_	_	_	_	_	_	_	O
5	on	_	on	_	IN	0	_	_	_	_	_	on.prep	Being_in_operation	O
6	cardiovascular	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
7	morbidity	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	0	_	_	_	_	_	_	_	O
9	all-cause	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	to.prep	Goal	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	assess.v	Assessing	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	extent.n	Quantity	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	to.prep	Goal	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	to.prep	Goal	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	associate.v	Collaboration	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	with.prep	Accompaniment	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	of.prep	Age	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	event.n	Event	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	mortality.n	Death	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	primary.a	First_rank	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	of.prep	Age	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	disease.n	Medical_conditions	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	different.a	Identicality	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	approach.n	Means	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	_	_	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	objectives	_	Objectives	_	NNS	1	_	_	_	_	_	_	_	O
2	:	_	:	_	:	1	_	_	_	_	_	_	_	O
3	to	_	To	_	TO	1	_	_	_	_	_	_	_	O
4	assess	_	assess	_	VB	1	_	_	_	_	_	_	_	O
5	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
6	extent	_	extent	_	NN	1	_	_	_	_	_	_	_	O
7	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
8	which	_	which	_	WDT	1	_	_	_	_	_	_	_	O
9	adherence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
11	statins	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
12	is	_	be	_	VBZ	1	_	_	_	_	_	_	_	O
13	associated	_	associate	_	VBN	1	_	_	_	_	_	_	_	O
14	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
15	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
16	incidence	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
17	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
18	cardiovascular	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
19	(	_	(	_	(	1	_	_	_	_	_	_	_	O
20	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
21	)	_	)	_	)	1	_	_	_	_	_	_	_	O
22	events	_	event	_	NNS	1	_	_	_	_	_	_	_	O
23	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
24	all	_	all	_	DT	1	_	_	_	_	_	_	_	O
25	cause	_	cause	_	VBP	1	_	_	_	_	_	_	_	O
26	mortality	_	mortality	_	NN	1	_	_	_	_	_	_	_	O
27	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
28	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
29	primary	_	primary	_	JJ	1	_	_	_	_	_	_	_	O
30	prevention	_	prevention	_	NN	1	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	1	_	_	_	_	_	_	_	O
32	cv	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
33	diseases	_	disease	_	NNS	1	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
35	whether	_	whether	_	IN	1	_	_	_	_	_	_	_	O
36	different	_	different	_	JJ	1	_	_	_	_	_	_	_	O
37	analytical	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
38	approaches	_	approach	_	NNS	1	_	_	_	_	_	_	_	O
39	influence	_	influence	_	VBP	1	_	_	_	_	_	_	_	O
40	the	_	the	_	DT	1	_	_	_	_	_	_	_	O
41	observed	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
42	associations	_	association	_	NNS	1	_	_	_	_	_	association.n	Organization	O
43	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
2	:	_	:	_	:	2	_	_	_	_	_	_	_	O
3	this	_	This	_	DT	2	_	_	_	_	_	_	_	O
4	population	_	population	_	NN	2	_	_	_	_	_	population.n	Aggregate	O
5	based	_	base	_	VBN	2	_	_	_	_	_	_	_	O
6	cohort	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
7	study	_	study	_	NN	2	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	2	_	_	_	_	_	_	_	O
9	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
11	finnish	_	Finnish	_	JJ	2	_	_	_	_	_	_	_	O
12	registers	_	register	_	NNS	2	_	_	_	_	_	_	_	O
13	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
2	:	_	:	_	:	2	_	_	_	_	_	_	_	O
3	this	_	This	_	DT	2	_	_	_	_	_	_	_	O
4	population	_	population	_	NN	2	_	_	_	_	_	_	_	O
5	based	_	base	_	VBN	2	_	_	_	_	_	base.n	Part_orientational	O
6	cohort	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
7	study	_	study	_	NN	2	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	2	_	_	_	_	_	_	_	O
9	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
11	finnish	_	Finnish	_	JJ	2	_	_	_	_	_	_	_	O
12	registers	_	register	_	NNS	2	_	_	_	_	_	_	_	O
13	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
2	:	_	:	_	:	2	_	_	_	_	_	_	_	O
3	this	_	This	_	DT	2	_	_	_	_	_	_	_	O
4	population	_	population	_	NN	2	_	_	_	_	_	_	_	O
5	based	_	base	_	VBN	2	_	_	_	_	_	_	_	O
6	cohort	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
7	study	_	study	_	NN	2	_	_	_	_	_	study.n	Building_subparts	O
8	used	_	use	_	VBN	2	_	_	_	_	_	_	_	O
9	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
11	finnish	_	Finnish	_	JJ	2	_	_	_	_	_	_	_	O
12	registers	_	register	_	NNS	2	_	_	_	_	_	_	_	O
13	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
2	:	_	:	_	:	2	_	_	_	_	_	_	_	O
3	this	_	This	_	DT	2	_	_	_	_	_	_	_	O
4	population	_	population	_	NN	2	_	_	_	_	_	_	_	O
5	based	_	base	_	VBN	2	_	_	_	_	_	_	_	O
6	cohort	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
7	study	_	study	_	NN	2	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	2	_	_	_	_	_	_	_	O
9	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	2	_	_	_	_	_	from.prep	Evidence	O
11	finnish	_	Finnish	_	JJ	2	_	_	_	_	_	_	_	O
12	registers	_	register	_	NNS	2	_	_	_	_	_	_	_	O
13	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	methods	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
2	:	_	:	_	:	2	_	_	_	_	_	_	_	O
3	this	_	This	_	DT	2	_	_	_	_	_	_	_	O
4	population	_	population	_	NN	2	_	_	_	_	_	_	_	O
5	based	_	base	_	VBN	2	_	_	_	_	_	_	_	O
6	cohort	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
7	study	_	study	_	NN	2	_	_	_	_	_	_	_	O
8	used	_	use	_	VBN	2	_	_	_	_	_	_	_	O
9	data	_	data	_	NNS	2	_	_	_	_	_	_	_	O
10	from	_	from	_	IN	2	_	_	_	_	_	_	_	O
11	finnish	_	Finnish	_	JJ	2	_	_	_	_	_	finnish.a	Origin	O
12	registers	_	register	_	NNS	2	_	_	_	_	_	_	_	O
13	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	cohort	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
3	included	_	include	_	VBD	3	_	_	_	_	_	include.v	Cause_to_be_included	O
4	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
5	new	_	new	_	JJ	3	_	_	_	_	_	_	_	O
6	statin	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
7	users	_	user	_	NNS	3	_	_	_	_	_	_	_	O
8	aged	_	age	_	VBD	3	_	_	_	_	_	_	_	O
9	45	_	45	_	CD	3	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
11	75	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
12	years	_	year	_	NNS	3	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
14	2001	_	2001	_	CD	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	2004	_	2004	_	CD	3	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
18	no	_	no	_	DT	3	_	_	_	_	_	_	_	O
19	cv	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
20	diseases	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	O
21	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
22	baseline	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	cohort	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
3	included	_	include	_	VBD	3	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
5	new	_	new	_	JJ	3	_	_	_	_	_	_	_	O
6	statin	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
7	users	_	user	_	NNS	3	_	_	_	_	_	_	_	O
8	aged	_	age	_	VBD	3	_	_	_	_	_	age.v	Aging	O
9	45	_	45	_	CD	3	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
11	75	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
12	years	_	year	_	NNS	3	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
14	2001	_	2001	_	CD	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	2004	_	2004	_	CD	3	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
18	no	_	no	_	DT	3	_	_	_	_	_	_	_	O
19	cv	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
20	diseases	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	O
21	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
22	baseline	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	cohort	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
3	included	_	include	_	VBD	3	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
5	new	_	new	_	JJ	3	_	_	_	_	_	_	_	O
6	statin	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
7	users	_	user	_	NNS	3	_	_	_	_	_	_	_	O
8	aged	_	age	_	VBD	3	_	_	_	_	_	_	_	O
9	45	_	45	_	CD	3	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	3	_	_	_	_	_	to.prep	Goal	O
11	75	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
12	years	_	year	_	NNS	3	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
14	2001	_	2001	_	CD	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	2004	_	2004	_	CD	3	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
18	no	_	no	_	DT	3	_	_	_	_	_	_	_	O
19	cv	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
20	diseases	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	O
21	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
22	baseline	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	cohort	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
3	included	_	include	_	VBD	3	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
5	new	_	new	_	JJ	3	_	_	_	_	_	_	_	O
6	statin	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
7	users	_	user	_	NNS	3	_	_	_	_	_	_	_	O
8	aged	_	age	_	VBD	3	_	_	_	_	_	_	_	O
9	45	_	45	_	CD	3	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
11	75	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
12	years	_	year	_	NNS	3	_	_	_	_	_	year.n	Measure_duration	O
13	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
14	2001	_	2001	_	CD	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	2004	_	2004	_	CD	3	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
18	no	_	no	_	DT	3	_	_	_	_	_	_	_	O
19	cv	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
20	diseases	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	O
21	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
22	baseline	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	cohort	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
3	included	_	include	_	VBD	3	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
5	new	_	new	_	JJ	3	_	_	_	_	_	_	_	O
6	statin	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
7	users	_	user	_	NNS	3	_	_	_	_	_	_	_	O
8	aged	_	age	_	VBD	3	_	_	_	_	_	_	_	O
9	45	_	45	_	CD	3	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
11	75	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
12	years	_	year	_	NNS	3	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
14	2001	_	2001	_	CD	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	to.prep	Goal	O
16	2004	_	2004	_	CD	3	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
18	no	_	no	_	DT	3	_	_	_	_	_	_	_	O
19	cv	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
20	diseases	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	O
21	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
22	baseline	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	cohort	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
3	included	_	include	_	VBD	3	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
5	new	_	new	_	JJ	3	_	_	_	_	_	_	_	O
6	statin	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
7	users	_	user	_	NNS	3	_	_	_	_	_	_	_	O
8	aged	_	age	_	VBD	3	_	_	_	_	_	_	_	O
9	45	_	45	_	CD	3	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
11	75	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
12	years	_	year	_	NNS	3	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
14	2001	_	2001	_	CD	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	2004	_	2004	_	CD	3	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
18	no	_	no	_	DT	3	_	_	_	_	_	no.art	Quantified_mass	O
19	cv	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
20	diseases	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	O
21	at	_	at	_	IN	3	_	_	_	_	_	_	_	O
22	baseline	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	cohort	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
3	included	_	include	_	VBD	3	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
5	new	_	new	_	JJ	3	_	_	_	_	_	_	_	O
6	statin	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
7	users	_	user	_	NNS	3	_	_	_	_	_	_	_	O
8	aged	_	age	_	VBD	3	_	_	_	_	_	_	_	O
9	45	_	45	_	CD	3	_	_	_	_	_	_	_	O
10	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
11	75	_	UNK	_	CD	3	_	_	_	_	_	_	_	O
12	years	_	year	_	NNS	3	_	_	_	_	_	_	_	O
13	in	_	in	_	IN	3	_	_	_	_	_	_	_	O
14	2001	_	2001	_	CD	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	2004	_	2004	_	CD	3	_	_	_	_	_	_	_	O
17	with	_	with	_	IN	3	_	_	_	_	_	_	_	O
18	no	_	no	_	DT	3	_	_	_	_	_	_	_	O
19	cv	_	UNK	_	NNP	3	_	_	_	_	_	_	_	O
20	diseases	_	UNK	_	VBZ	3	_	_	_	_	_	_	_	O
21	at	_	at	_	IN	3	_	_	_	_	_	at.prep	Locative_relation	O
22	baseline	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
23	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	exposure	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
3	defined	_	define	_	VBN	4	_	_	_	_	_	define.v	Categorization	O
4	as	_	a	_	IN	4	_	_	_	_	_	_	_	O
5	adherence	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	4	_	_	_	_	_	_	_	O
7	statins	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	proportion	_	proportion	_	NN	4	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
11	days	_	day	_	NNS	4	_	_	_	_	_	_	_	O
12	covered	_	cover	_	VBN	4	_	_	_	_	_	_	_	O
13	[	_	[	_	JJ	4	_	_	_	_	_	_	_	O
14	pdc	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
15	]	_	]	_	NNP	4	_	_	_	_	_	_	_	O
16	)	_	)	_	)	4	_	_	_	_	_	_	_	O
17	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	exposure	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
3	defined	_	define	_	VBN	4	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	4	_	_	_	_	_	_	_	O
5	adherence	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	4	_	_	_	_	_	to.prep	Goal	O
7	statins	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	proportion	_	proportion	_	NN	4	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
11	days	_	day	_	NNS	4	_	_	_	_	_	_	_	O
12	covered	_	cover	_	VBN	4	_	_	_	_	_	_	_	O
13	[	_	[	_	JJ	4	_	_	_	_	_	_	_	O
14	pdc	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
15	]	_	]	_	NNP	4	_	_	_	_	_	_	_	O
16	)	_	)	_	)	4	_	_	_	_	_	_	_	O
17	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	exposure	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
3	defined	_	define	_	VBN	4	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	4	_	_	_	_	_	_	_	O
5	adherence	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	4	_	_	_	_	_	_	_	O
7	statins	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	proportion	_	proportion	_	NN	4	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	4	_	_	_	_	_	of.prep	Age	O
11	days	_	day	_	NNS	4	_	_	_	_	_	_	_	O
12	covered	_	cover	_	VBN	4	_	_	_	_	_	_	_	O
13	[	_	[	_	JJ	4	_	_	_	_	_	_	_	O
14	pdc	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
15	]	_	]	_	NNP	4	_	_	_	_	_	_	_	O
16	)	_	)	_	)	4	_	_	_	_	_	_	_	O
17	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	exposure	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
3	defined	_	define	_	VBN	4	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	4	_	_	_	_	_	_	_	O
5	adherence	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	4	_	_	_	_	_	_	_	O
7	statins	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	proportion	_	proportion	_	NN	4	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
11	days	_	day	_	NNS	4	_	_	_	_	_	day.n	Measure_duration	O
12	covered	_	cover	_	VBN	4	_	_	_	_	_	_	_	O
13	[	_	[	_	JJ	4	_	_	_	_	_	_	_	O
14	pdc	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
15	]	_	]	_	NNP	4	_	_	_	_	_	_	_	O
16	)	_	)	_	)	4	_	_	_	_	_	_	_	O
17	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	exposure	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
2	was	_	be	_	VBD	4	_	_	_	_	_	_	_	O
3	defined	_	define	_	VBN	4	_	_	_	_	_	_	_	O
4	as	_	a	_	IN	4	_	_	_	_	_	_	_	O
5	adherence	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
6	to	_	to	_	TO	4	_	_	_	_	_	_	_	O
7	statins	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
8	(	_	(	_	(	4	_	_	_	_	_	_	_	O
9	proportion	_	proportion	_	NN	4	_	_	_	_	_	_	_	O
10	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
11	days	_	day	_	NNS	4	_	_	_	_	_	_	_	O
12	covered	_	cover	_	VBN	4	_	_	_	_	_	cover.v	Protecting	O
13	[	_	[	_	JJ	4	_	_	_	_	_	_	_	O
14	pdc	_	UNK	_	NNP	4	_	_	_	_	_	_	_	O
15	]	_	]	_	NNP	4	_	_	_	_	_	_	_	O
16	)	_	)	_	)	4	_	_	_	_	_	_	_	O
17	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	5	_	_	_	_	_	_	_	O
2	primary	_	primary	_	JJ	5	_	_	_	_	_	primary.a	First_rank	O
3	outcome	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
4	was	_	be	_	VBD	5	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	5	_	_	_	_	_	_	_	O
6	cv	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
7	event	_	event	_	NN	5	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	5	_	_	_	_	_	_	_	O
9	death	_	death	_	NN	5	_	_	_	_	_	_	_	O
10	during	_	during	_	IN	5	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	5	_	_	_	_	_	_	_	O
12	3-year	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
13	follow-up	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
14	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	5	_	_	_	_	_	_	_	O
2	primary	_	primary	_	JJ	5	_	_	_	_	_	_	_	O
3	outcome	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
4	was	_	be	_	VBD	5	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	5	_	_	_	_	_	any.a	Quantified_mass	O
6	cv	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
7	event	_	event	_	NN	5	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	5	_	_	_	_	_	_	_	O
9	death	_	death	_	NN	5	_	_	_	_	_	_	_	O
10	during	_	during	_	IN	5	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	5	_	_	_	_	_	_	_	O
12	3-year	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
13	follow-up	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
14	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	5	_	_	_	_	_	_	_	O
2	primary	_	primary	_	JJ	5	_	_	_	_	_	_	_	O
3	outcome	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
4	was	_	be	_	VBD	5	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	5	_	_	_	_	_	_	_	O
6	cv	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
7	event	_	event	_	NN	5	_	_	_	_	_	event.n	Event	O
8	or	_	or	_	CC	5	_	_	_	_	_	_	_	O
9	death	_	death	_	NN	5	_	_	_	_	_	_	_	O
10	during	_	during	_	IN	5	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	5	_	_	_	_	_	_	_	O
12	3-year	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
13	follow-up	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
14	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	5	_	_	_	_	_	_	_	O
2	primary	_	primary	_	JJ	5	_	_	_	_	_	_	_	O
3	outcome	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
4	was	_	be	_	VBD	5	_	_	_	_	_	_	_	O
5	any	_	any	_	DT	5	_	_	_	_	_	_	_	O
6	cv	_	UNK	_	NNP	5	_	_	_	_	_	_	_	O
7	event	_	event	_	NN	5	_	_	_	_	_	_	_	O
8	or	_	or	_	CC	5	_	_	_	_	_	_	_	O
9	death	_	death	_	NN	5	_	_	_	_	_	death.n	Death	O
10	during	_	during	_	IN	5	_	_	_	_	_	_	_	O
11	a	_	a	_	DT	5	_	_	_	_	_	_	_	O
12	3-year	_	UNK	_	JJ	5	_	_	_	_	_	_	_	O
13	follow-up	_	UNK	_	NN	5	_	_	_	_	_	_	_	O
14	.	_	.	_	.	5	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	6	_	_	_	_	_	different.a	Identicality	O
2	analytical	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
3	approaches	_	approach	_	NNS	6	_	_	_	_	_	_	_	O
4	,	_	,	_	,	6	_	_	_	_	_	_	_	O
5	including	_	include	_	VBG	6	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
7	cox	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
8	regression	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	,	_	,	_	,	6	_	_	_	_	_	_	_	O
10	inverse	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
11	probability	_	probability	_	NN	6	_	_	_	_	_	_	_	O
12	weighting	_	weight	_	VBG	6	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
14	time	_	time	_	NN	6	_	_	_	_	_	_	_	O
15	varying	_	vary	_	VBG	6	_	_	_	_	_	_	_	O
16	adherence	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
17	,	_	,	_	,	6	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
19	propensity	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
20	score	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
21	calibration	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
22	,	_	,	_	,	6	_	_	_	_	_	_	_	O
23	were	_	be	_	VBD	6	_	_	_	_	_	_	_	O
24	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
25	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	6	_	_	_	_	_	_	_	O
2	analytical	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
3	approaches	_	approach	_	NNS	6	_	_	_	_	_	approach.n	Means	O
4	,	_	,	_	,	6	_	_	_	_	_	_	_	O
5	including	_	include	_	VBG	6	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
7	cox	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
8	regression	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	,	_	,	_	,	6	_	_	_	_	_	_	_	O
10	inverse	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
11	probability	_	probability	_	NN	6	_	_	_	_	_	_	_	O
12	weighting	_	weight	_	VBG	6	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
14	time	_	time	_	NN	6	_	_	_	_	_	_	_	O
15	varying	_	vary	_	VBG	6	_	_	_	_	_	_	_	O
16	adherence	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
17	,	_	,	_	,	6	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
19	propensity	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
20	score	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
21	calibration	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
22	,	_	,	_	,	6	_	_	_	_	_	_	_	O
23	were	_	be	_	VBD	6	_	_	_	_	_	_	_	O
24	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
25	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	6	_	_	_	_	_	_	_	O
2	analytical	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
3	approaches	_	approach	_	NNS	6	_	_	_	_	_	_	_	O
4	,	_	,	_	,	6	_	_	_	_	_	_	_	O
5	including	_	include	_	VBG	6	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
7	cox	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
8	regression	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	,	_	,	_	,	6	_	_	_	_	_	_	_	O
10	inverse	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
11	probability	_	probability	_	NN	6	_	_	_	_	_	_	_	O
12	weighting	_	weight	_	VBG	6	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
14	time	_	time	_	NN	6	_	_	_	_	_	time.n	Measure_duration	O
15	varying	_	vary	_	VBG	6	_	_	_	_	_	_	_	O
16	adherence	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
17	,	_	,	_	,	6	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
19	propensity	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
20	score	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
21	calibration	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
22	,	_	,	_	,	6	_	_	_	_	_	_	_	O
23	were	_	be	_	VBD	6	_	_	_	_	_	_	_	O
24	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
25	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	6	_	_	_	_	_	_	_	O
2	analytical	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
3	approaches	_	approach	_	NNS	6	_	_	_	_	_	_	_	O
4	,	_	,	_	,	6	_	_	_	_	_	_	_	O
5	including	_	include	_	VBG	6	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
7	cox	_	UNK	_	NNP	6	_	_	_	_	_	_	_	O
8	regression	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
9	,	_	,	_	,	6	_	_	_	_	_	_	_	O
10	inverse	_	UNK	_	JJ	6	_	_	_	_	_	_	_	O
11	probability	_	probability	_	NN	6	_	_	_	_	_	_	_	O
12	weighting	_	weight	_	VBG	6	_	_	_	_	_	_	_	O
13	with	_	with	_	IN	6	_	_	_	_	_	_	_	O
14	time	_	time	_	NN	6	_	_	_	_	_	_	_	O
15	varying	_	vary	_	VBG	6	_	_	_	_	_	vary.v	Cause_change	O
16	adherence	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
17	,	_	,	_	,	6	_	_	_	_	_	_	_	O
18	and	_	and	_	CC	6	_	_	_	_	_	_	_	O
19	propensity	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
20	score	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
21	calibration	_	UNK	_	NN	6	_	_	_	_	_	_	_	O
22	,	_	,	_	,	6	_	_	_	_	_	_	_	O
23	were	_	be	_	VBD	6	_	_	_	_	_	_	_	O
24	used	_	use	_	VBN	6	_	_	_	_	_	_	_	O
25	.	_	.	_	.	6	_	_	_	_	_	_	_	O

1	results	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	during	_	During	_	IN	7	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
5	first	_	first	_	JJ	7	_	_	_	_	_	_	_	O
6	year	_	year	_	NN	7	_	_	_	_	_	year.n	Measure_duration	O
7	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
8	follow-up	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
9	,	_	,	_	,	7	_	_	_	_	_	_	_	O
10	53	_	53	_	CD	7	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
12	displayed	_	display	_	VBN	7	_	_	_	_	_	_	_	O
13	good	_	good	_	JJ	7	_	_	_	_	_	_	_	O
14	(	_	(	_	(	7	_	_	_	_	_	_	_	O
15	pdc	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
16	>	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
17	=	_	UNK	_	VBD	7	_	_	_	_	_	_	_	O
18	80	_	80	_	CD	7	_	_	_	_	_	_	_	O
19	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
20	)	_	)	_	)	7	_	_	_	_	_	_	_	O
21	,	_	,	_	,	7	_	_	_	_	_	_	_	O
22	26	_	26	_	CD	7	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
24	had	_	have	_	VBD	7	_	_	_	_	_	_	_	O
25	intermediate	_	intermediate	_	JJ	7	_	_	_	_	_	_	_	O
26	(	_	(	_	(	7	_	_	_	_	_	_	_	O
27	pdc	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
28	40	_	40	_	CD	7	_	_	_	_	_	_	_	O
29	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
30	-79	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
31	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
32	)	_	)	_	)	7	_	_	_	_	_	_	_	O
33	,	_	,	_	,	7	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
35	21	_	21	_	CD	7	_	_	_	_	_	_	_	O
36	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
37	exhibited	_	exhibit	_	VBN	7	_	_	_	_	_	_	_	O
38	poor	_	poor	_	JJ	7	_	_	_	_	_	_	_	O
39	(	_	(	_	(	7	_	_	_	_	_	_	_	O
40	pdc	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
41	<	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
42	40	_	40	_	CD	7	_	_	_	_	_	_	_	O
43	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
44	)	_	)	_	)	7	_	_	_	_	_	_	_	O
45	adherence	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
46	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	results	_	UNK	_	NNS	7	_	_	_	_	_	_	_	O
2	:	_	:	_	:	7	_	_	_	_	_	_	_	O
3	during	_	During	_	IN	7	_	_	_	_	_	_	_	O
4	the	_	the	_	DT	7	_	_	_	_	_	_	_	O
5	first	_	first	_	JJ	7	_	_	_	_	_	_	_	O
6	year	_	year	_	NN	7	_	_	_	_	_	_	_	O
7	of	_	of	_	IN	7	_	_	_	_	_	_	_	O
8	follow-up	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
9	,	_	,	_	,	7	_	_	_	_	_	_	_	O
10	53	_	53	_	CD	7	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
12	displayed	_	display	_	VBN	7	_	_	_	_	_	_	_	O
13	good	_	good	_	JJ	7	_	_	_	_	_	good.a	Expertise	O
14	(	_	(	_	(	7	_	_	_	_	_	_	_	O
15	pdc	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
16	>	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
17	=	_	UNK	_	VBD	7	_	_	_	_	_	_	_	O
18	80	_	80	_	CD	7	_	_	_	_	_	_	_	O
19	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
20	)	_	)	_	)	7	_	_	_	_	_	_	_	O
21	,	_	,	_	,	7	_	_	_	_	_	_	_	O
22	26	_	26	_	CD	7	_	_	_	_	_	_	_	O
23	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
24	had	_	have	_	VBD	7	_	_	_	_	_	_	_	O
25	intermediate	_	intermediate	_	JJ	7	_	_	_	_	_	_	_	O
26	(	_	(	_	(	7	_	_	_	_	_	_	_	O
27	pdc	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
28	40	_	40	_	CD	7	_	_	_	_	_	_	_	O
29	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
30	-79	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
31	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
32	)	_	)	_	)	7	_	_	_	_	_	_	_	O
33	,	_	,	_	,	7	_	_	_	_	_	_	_	O
34	and	_	and	_	CC	7	_	_	_	_	_	_	_	O
35	21	_	21	_	CD	7	_	_	_	_	_	_	_	O
36	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
37	exhibited	_	exhibit	_	VBN	7	_	_	_	_	_	_	_	O
38	poor	_	poor	_	JJ	7	_	_	_	_	_	_	_	O
39	(	_	(	_	(	7	_	_	_	_	_	_	_	O
40	pdc	_	UNK	_	NNP	7	_	_	_	_	_	_	_	O
41	<	_	UNK	_	RB	7	_	_	_	_	_	_	_	O
42	40	_	40	_	CD	7	_	_	_	_	_	_	_	O
43	%	_	%	_	NN	7	_	_	_	_	_	_	_	O
44	)	_	)	_	)	7	_	_	_	_	_	_	_	O
45	adherence	_	UNK	_	NN	7	_	_	_	_	_	_	_	O
46	.	_	.	_	.	7	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	for.prep	Taking_sides	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	relative.n	Kinship	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	risk.n	Being_at_risk	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	reduction.n	Cause_expansion	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	hazard.v	Statement	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	observe.v	Condition_symptom_relation	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	rate.n	Speed_description	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	of.prep	Age	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	any.a	Quantified_mass	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	death.n	Death	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	_	_	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	after	_	After	_	IN	8	_	_	_	_	_	_	_	O
2	adjustment	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
3	for	_	for	_	IN	8	_	_	_	_	_	_	_	O
4	unk	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
5	and	_	and	_	CC	8	_	_	_	_	_	_	_	O
6	clinical	_	UNK	_	JJ	8	_	_	_	_	_	_	_	O
7	covariates	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
8	,	_	,	_	,	8	_	_	_	_	_	_	_	O
9	a	_	a	_	DT	8	_	_	_	_	_	_	_	O
10	25	_	25	_	CD	8	_	_	_	_	_	_	_	O
11	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
12	relative	_	relative	_	JJ	8	_	_	_	_	_	_	_	O
13	risk	_	risk	_	NN	8	_	_	_	_	_	_	_	O
14	reduction	_	reduction	_	NN	8	_	_	_	_	_	_	_	O
15	(	_	(	_	(	8	_	_	_	_	_	_	_	O
16	hazard	_	hazard	_	JJ	8	_	_	_	_	_	_	_	O
17	ratio	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
18	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
19	hr	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
20	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
21	0.75	_	UNK	_	CD	8	_	_	_	_	_	_	_	O
22	;	_	;	_	:	8	_	_	_	_	_	_	_	O
23	95	_	95	_	CD	8	_	_	_	_	_	_	_	O
24	%	_	%	_	NN	8	_	_	_	_	_	_	_	O
25	confidence	_	confidence	_	NN	8	_	_	_	_	_	_	_	O
26	interval	_	interval	_	NN	8	_	_	_	_	_	_	_	O
27	[	_	[	_	NNP	8	_	_	_	_	_	_	_	O
28	ci	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
29	]	_	]	_	NNP	8	_	_	_	_	_	_	_	O
30	unk	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
31	)	_	)	_	)	8	_	_	_	_	_	_	_	O
32	was	_	be	_	VBD	8	_	_	_	_	_	_	_	O
33	observed	_	observe	_	VBN	8	_	_	_	_	_	_	_	O
34	in	_	in	_	IN	8	_	_	_	_	_	_	_	O
35	the	_	the	_	DT	8	_	_	_	_	_	_	_	O
36	rate	_	rate	_	NN	8	_	_	_	_	_	_	_	O
37	of	_	of	_	IN	8	_	_	_	_	_	_	_	O
38	any	_	any	_	DT	8	_	_	_	_	_	_	_	O
39	cv	_	UNK	_	NNP	8	_	_	_	_	_	_	_	O
40	event	_	event	_	NN	8	_	_	_	_	_	_	_	O
41	or	_	or	_	CC	8	_	_	_	_	_	_	_	O
42	death	_	death	_	NN	8	_	_	_	_	_	_	_	O
43	among	_	among	_	IN	8	_	_	_	_	_	_	_	O
44	good	_	good	_	JJ	8	_	_	_	_	_	good.a	Expertise	O
45	versus	_	UNK	_	NN	8	_	_	_	_	_	_	_	O
46	poor	_	poor	_	JJ	8	_	_	_	_	_	_	_	O
47	unk	_	UNK	_	NNS	8	_	_	_	_	_	_	_	O
48	.	_	.	_	.	8	_	_	_	_	_	_	_	O

1	good	_	Good	_	JJ	9	_	_	_	_	_	good.a	Expertise	O
2	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
3	also	_	also	_	RB	9	_	_	_	_	_	_	_	O
4	had	_	have	_	VBD	9	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	9	_	_	_	_	_	_	_	O
6	lower	_	lower	_	JJR	9	_	_	_	_	_	_	_	O
7	incidence	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
8	than	_	than	_	IN	9	_	_	_	_	_	_	_	O
9	poor	_	poor	_	JJ	9	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
12	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
13	coronary	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
14	syndrome	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
15	(	_	(	_	(	9	_	_	_	_	_	_	_	O
16	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
17	0.56	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
18	;	_	;	_	:	9	_	_	_	_	_	_	_	O
19	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
21	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
23	)	_	)	_	)	9	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
25	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
26	cerebrovascular	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
27	disease	_	disease	_	NN	9	_	_	_	_	_	_	_	O
28	events	_	event	_	NNS	9	_	_	_	_	_	_	_	O
29	(	_	(	_	(	9	_	_	_	_	_	_	_	O
30	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
31	0.67	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
32	;	_	;	_	:	9	_	_	_	_	_	_	_	O
33	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
34	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
35	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
37	)	_	)	_	)	9	_	_	_	_	_	_	_	O
38	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	good	_	Good	_	JJ	9	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
3	also	_	also	_	RB	9	_	_	_	_	_	_	_	O
4	had	_	have	_	VBD	9	_	_	_	_	_	have.v	Possession	O
5	a	_	a	_	DT	9	_	_	_	_	_	_	_	O
6	lower	_	lower	_	JJR	9	_	_	_	_	_	_	_	O
7	incidence	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
8	than	_	than	_	IN	9	_	_	_	_	_	_	_	O
9	poor	_	poor	_	JJ	9	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
12	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
13	coronary	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
14	syndrome	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
15	(	_	(	_	(	9	_	_	_	_	_	_	_	O
16	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
17	0.56	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
18	;	_	;	_	:	9	_	_	_	_	_	_	_	O
19	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
21	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
23	)	_	)	_	)	9	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
25	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
26	cerebrovascular	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
27	disease	_	disease	_	NN	9	_	_	_	_	_	_	_	O
28	events	_	event	_	NNS	9	_	_	_	_	_	_	_	O
29	(	_	(	_	(	9	_	_	_	_	_	_	_	O
30	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
31	0.67	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
32	;	_	;	_	:	9	_	_	_	_	_	_	_	O
33	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
34	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
35	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
37	)	_	)	_	)	9	_	_	_	_	_	_	_	O
38	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	good	_	Good	_	JJ	9	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
3	also	_	also	_	RB	9	_	_	_	_	_	_	_	O
4	had	_	have	_	VBD	9	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	9	_	_	_	_	_	_	_	O
6	lower	_	lower	_	JJR	9	_	_	_	_	_	lower.v	Change_position_on_a_scale	O
7	incidence	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
8	than	_	than	_	IN	9	_	_	_	_	_	_	_	O
9	poor	_	poor	_	JJ	9	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
12	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
13	coronary	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
14	syndrome	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
15	(	_	(	_	(	9	_	_	_	_	_	_	_	O
16	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
17	0.56	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
18	;	_	;	_	:	9	_	_	_	_	_	_	_	O
19	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
21	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
23	)	_	)	_	)	9	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
25	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
26	cerebrovascular	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
27	disease	_	disease	_	NN	9	_	_	_	_	_	_	_	O
28	events	_	event	_	NNS	9	_	_	_	_	_	_	_	O
29	(	_	(	_	(	9	_	_	_	_	_	_	_	O
30	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
31	0.67	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
32	;	_	;	_	:	9	_	_	_	_	_	_	_	O
33	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
34	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
35	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
37	)	_	)	_	)	9	_	_	_	_	_	_	_	O
38	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	good	_	Good	_	JJ	9	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
3	also	_	also	_	RB	9	_	_	_	_	_	_	_	O
4	had	_	have	_	VBD	9	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	9	_	_	_	_	_	_	_	O
6	lower	_	lower	_	JJR	9	_	_	_	_	_	_	_	O
7	incidence	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
8	than	_	than	_	IN	9	_	_	_	_	_	_	_	O
9	poor	_	poor	_	JJ	9	_	_	_	_	_	poor.a	Luck	O
10	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
12	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
13	coronary	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
14	syndrome	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
15	(	_	(	_	(	9	_	_	_	_	_	_	_	O
16	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
17	0.56	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
18	;	_	;	_	:	9	_	_	_	_	_	_	_	O
19	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
21	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
23	)	_	)	_	)	9	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
25	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
26	cerebrovascular	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
27	disease	_	disease	_	NN	9	_	_	_	_	_	_	_	O
28	events	_	event	_	NNS	9	_	_	_	_	_	_	_	O
29	(	_	(	_	(	9	_	_	_	_	_	_	_	O
30	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
31	0.67	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
32	;	_	;	_	:	9	_	_	_	_	_	_	_	O
33	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
34	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
35	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
37	)	_	)	_	)	9	_	_	_	_	_	_	_	O
38	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	good	_	Good	_	JJ	9	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
3	also	_	also	_	RB	9	_	_	_	_	_	_	_	O
4	had	_	have	_	VBD	9	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	9	_	_	_	_	_	_	_	O
6	lower	_	lower	_	JJR	9	_	_	_	_	_	_	_	O
7	incidence	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
8	than	_	than	_	IN	9	_	_	_	_	_	_	_	O
9	poor	_	poor	_	JJ	9	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	9	_	_	_	_	_	of.prep	Age	O
12	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
13	coronary	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
14	syndrome	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
15	(	_	(	_	(	9	_	_	_	_	_	_	_	O
16	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
17	0.56	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
18	;	_	;	_	:	9	_	_	_	_	_	_	_	O
19	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
21	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
23	)	_	)	_	)	9	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
25	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
26	cerebrovascular	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
27	disease	_	disease	_	NN	9	_	_	_	_	_	_	_	O
28	events	_	event	_	NNS	9	_	_	_	_	_	_	_	O
29	(	_	(	_	(	9	_	_	_	_	_	_	_	O
30	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
31	0.67	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
32	;	_	;	_	:	9	_	_	_	_	_	_	_	O
33	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
34	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
35	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
37	)	_	)	_	)	9	_	_	_	_	_	_	_	O
38	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	good	_	Good	_	JJ	9	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
3	also	_	also	_	RB	9	_	_	_	_	_	_	_	O
4	had	_	have	_	VBD	9	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	9	_	_	_	_	_	_	_	O
6	lower	_	lower	_	JJR	9	_	_	_	_	_	_	_	O
7	incidence	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
8	than	_	than	_	IN	9	_	_	_	_	_	_	_	O
9	poor	_	poor	_	JJ	9	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
12	acute	_	acute	_	JJ	9	_	_	_	_	_	acute.a	Importance	O
13	coronary	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
14	syndrome	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
15	(	_	(	_	(	9	_	_	_	_	_	_	_	O
16	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
17	0.56	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
18	;	_	;	_	:	9	_	_	_	_	_	_	_	O
19	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
21	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
23	)	_	)	_	)	9	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
25	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
26	cerebrovascular	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
27	disease	_	disease	_	NN	9	_	_	_	_	_	_	_	O
28	events	_	event	_	NNS	9	_	_	_	_	_	_	_	O
29	(	_	(	_	(	9	_	_	_	_	_	_	_	O
30	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
31	0.67	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
32	;	_	;	_	:	9	_	_	_	_	_	_	_	O
33	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
34	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
35	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
37	)	_	)	_	)	9	_	_	_	_	_	_	_	O
38	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	good	_	Good	_	JJ	9	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
3	also	_	also	_	RB	9	_	_	_	_	_	_	_	O
4	had	_	have	_	VBD	9	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	9	_	_	_	_	_	_	_	O
6	lower	_	lower	_	JJR	9	_	_	_	_	_	_	_	O
7	incidence	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
8	than	_	than	_	IN	9	_	_	_	_	_	_	_	O
9	poor	_	poor	_	JJ	9	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
12	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
13	coronary	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
14	syndrome	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
15	(	_	(	_	(	9	_	_	_	_	_	_	_	O
16	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
17	0.56	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
18	;	_	;	_	:	9	_	_	_	_	_	_	_	O
19	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
21	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
23	)	_	)	_	)	9	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
25	acute	_	acute	_	JJ	9	_	_	_	_	_	acute.a	Importance	O
26	cerebrovascular	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
27	disease	_	disease	_	NN	9	_	_	_	_	_	_	_	O
28	events	_	event	_	NNS	9	_	_	_	_	_	_	_	O
29	(	_	(	_	(	9	_	_	_	_	_	_	_	O
30	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
31	0.67	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
32	;	_	;	_	:	9	_	_	_	_	_	_	_	O
33	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
34	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
35	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
37	)	_	)	_	)	9	_	_	_	_	_	_	_	O
38	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	good	_	Good	_	JJ	9	_	_	_	_	_	_	_	O
2	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
3	also	_	also	_	RB	9	_	_	_	_	_	_	_	O
4	had	_	have	_	VBD	9	_	_	_	_	_	_	_	O
5	a	_	a	_	DT	9	_	_	_	_	_	_	_	O
6	lower	_	lower	_	JJR	9	_	_	_	_	_	_	_	O
7	incidence	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
8	than	_	than	_	IN	9	_	_	_	_	_	_	_	O
9	poor	_	poor	_	JJ	9	_	_	_	_	_	_	_	O
10	unk	_	UNK	_	NNS	9	_	_	_	_	_	_	_	O
11	of	_	of	_	IN	9	_	_	_	_	_	_	_	O
12	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
13	coronary	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
14	syndrome	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
15	(	_	(	_	(	9	_	_	_	_	_	_	_	O
16	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
17	0.56	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
18	;	_	;	_	:	9	_	_	_	_	_	_	_	O
19	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
20	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
21	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
22	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
23	)	_	)	_	)	9	_	_	_	_	_	_	_	O
24	and	_	and	_	CC	9	_	_	_	_	_	_	_	O
25	acute	_	acute	_	JJ	9	_	_	_	_	_	_	_	O
26	cerebrovascular	_	UNK	_	JJ	9	_	_	_	_	_	_	_	O
27	disease	_	disease	_	NN	9	_	_	_	_	_	disease.n	Medical_conditions	O
28	events	_	event	_	NNS	9	_	_	_	_	_	_	_	O
29	(	_	(	_	(	9	_	_	_	_	_	_	_	O
30	hr	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
31	0.67	_	UNK	_	CD	9	_	_	_	_	_	_	_	O
32	;	_	;	_	:	9	_	_	_	_	_	_	_	O
33	95	_	95	_	CD	9	_	_	_	_	_	_	_	O
34	%	_	%	_	NN	9	_	_	_	_	_	_	_	O
35	ci	_	UNK	_	NNP	9	_	_	_	_	_	_	_	O
36	unk	_	UNK	_	NN	9	_	_	_	_	_	_	_	O
37	)	_	)	_	)	9	_	_	_	_	_	_	_	O
38	.	_	.	_	.	9	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	O
2	different	_	different	_	JJ	10	_	_	_	_	_	different.a	Identicality	O
3	analytical	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
4	approaches	_	approach	_	NNS	10	_	_	_	_	_	_	_	O
5	achieved	_	achieve	_	VBN	10	_	_	_	_	_	_	_	O
6	comparable	_	comparable	_	JJ	10	_	_	_	_	_	_	_	O
7	results	_	result	_	NNS	10	_	_	_	_	_	_	_	O
8	for	_	for	_	IN	10	_	_	_	_	_	_	_	O
9	all	_	all	_	PDT	10	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
11	outcomes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
12	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	O
2	different	_	different	_	JJ	10	_	_	_	_	_	_	_	O
3	analytical	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
4	approaches	_	approach	_	NNS	10	_	_	_	_	_	approach.n	Means	O
5	achieved	_	achieve	_	VBN	10	_	_	_	_	_	_	_	O
6	comparable	_	comparable	_	JJ	10	_	_	_	_	_	_	_	O
7	results	_	result	_	NNS	10	_	_	_	_	_	_	_	O
8	for	_	for	_	IN	10	_	_	_	_	_	_	_	O
9	all	_	all	_	PDT	10	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
11	outcomes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
12	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	O
2	different	_	different	_	JJ	10	_	_	_	_	_	_	_	O
3	analytical	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
4	approaches	_	approach	_	NNS	10	_	_	_	_	_	_	_	O
5	achieved	_	achieve	_	VBN	10	_	_	_	_	_	achieve.v	Accomplishment	O
6	comparable	_	comparable	_	JJ	10	_	_	_	_	_	_	_	O
7	results	_	result	_	NNS	10	_	_	_	_	_	_	_	O
8	for	_	for	_	IN	10	_	_	_	_	_	_	_	O
9	all	_	all	_	PDT	10	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
11	outcomes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
12	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	O
2	different	_	different	_	JJ	10	_	_	_	_	_	_	_	O
3	analytical	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
4	approaches	_	approach	_	NNS	10	_	_	_	_	_	_	_	O
5	achieved	_	achieve	_	VBN	10	_	_	_	_	_	_	_	O
6	comparable	_	comparable	_	JJ	10	_	_	_	_	_	comparable.a	Evaluative_comparison	O
7	results	_	result	_	NNS	10	_	_	_	_	_	_	_	O
8	for	_	for	_	IN	10	_	_	_	_	_	_	_	O
9	all	_	all	_	PDT	10	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
11	outcomes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
12	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	O
2	different	_	different	_	JJ	10	_	_	_	_	_	_	_	O
3	analytical	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
4	approaches	_	approach	_	NNS	10	_	_	_	_	_	_	_	O
5	achieved	_	achieve	_	VBN	10	_	_	_	_	_	_	_	O
6	comparable	_	comparable	_	JJ	10	_	_	_	_	_	_	_	O
7	results	_	result	_	NNS	10	_	_	_	_	_	result.n	Earnings_and_losses	O
8	for	_	for	_	IN	10	_	_	_	_	_	_	_	O
9	all	_	all	_	PDT	10	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
11	outcomes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
12	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	10	_	_	_	_	_	_	_	O
2	different	_	different	_	JJ	10	_	_	_	_	_	_	_	O
3	analytical	_	UNK	_	JJ	10	_	_	_	_	_	_	_	O
4	approaches	_	approach	_	NNS	10	_	_	_	_	_	_	_	O
5	achieved	_	achieve	_	VBN	10	_	_	_	_	_	_	_	O
6	comparable	_	comparable	_	JJ	10	_	_	_	_	_	_	_	O
7	results	_	result	_	NNS	10	_	_	_	_	_	_	_	O
8	for	_	for	_	IN	10	_	_	_	_	_	for.prep	Taking_sides	O
9	all	_	all	_	PDT	10	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	10	_	_	_	_	_	_	_	O
11	outcomes	_	UNK	_	NNS	10	_	_	_	_	_	_	_	O
12	.	_	.	_	.	10	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	incidence	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	11	_	_	_	_	_	of.prep	Age	O
6	cv	_	UNK	_	NNP	11	_	_	_	_	_	_	_	O
7	events	_	event	_	NNS	11	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	11	_	_	_	_	_	_	_	O
9	mortality	_	mortality	_	NN	11	_	_	_	_	_	_	_	O
10	was	_	be	_	VBD	11	_	_	_	_	_	_	_	O
11	higher	_	higher	_	RBR	11	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
13	poor	_	poor	_	JJ	11	_	_	_	_	_	_	_	O
14	versus	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
15	good	_	good	_	JJ	11	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
17	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	incidence	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
6	cv	_	UNK	_	NNP	11	_	_	_	_	_	_	_	O
7	events	_	event	_	NNS	11	_	_	_	_	_	event.n	Event	O
8	and	_	and	_	CC	11	_	_	_	_	_	_	_	O
9	mortality	_	mortality	_	NN	11	_	_	_	_	_	_	_	O
10	was	_	be	_	VBD	11	_	_	_	_	_	_	_	O
11	higher	_	higher	_	RBR	11	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
13	poor	_	poor	_	JJ	11	_	_	_	_	_	_	_	O
14	versus	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
15	good	_	good	_	JJ	11	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
17	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	incidence	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
6	cv	_	UNK	_	NNP	11	_	_	_	_	_	_	_	O
7	events	_	event	_	NNS	11	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	11	_	_	_	_	_	_	_	O
9	mortality	_	mortality	_	NN	11	_	_	_	_	_	mortality.n	Death	O
10	was	_	be	_	VBD	11	_	_	_	_	_	_	_	O
11	higher	_	higher	_	RBR	11	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
13	poor	_	poor	_	JJ	11	_	_	_	_	_	_	_	O
14	versus	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
15	good	_	good	_	JJ	11	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
17	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	incidence	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
6	cv	_	UNK	_	NNP	11	_	_	_	_	_	_	_	O
7	events	_	event	_	NNS	11	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	11	_	_	_	_	_	_	_	O
9	mortality	_	mortality	_	NN	11	_	_	_	_	_	_	_	O
10	was	_	be	_	VBD	11	_	_	_	_	_	_	_	O
11	higher	_	higher	_	RBR	11	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
13	poor	_	poor	_	JJ	11	_	_	_	_	_	poor.a	Luck	O
14	versus	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
15	good	_	good	_	JJ	11	_	_	_	_	_	_	_	O
16	unk	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
17	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	conclusions	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
2	:	_	:	_	:	11	_	_	_	_	_	_	_	O
3	the	_	The	_	DT	11	_	_	_	_	_	_	_	O
4	incidence	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	11	_	_	_	_	_	_	_	O
6	cv	_	UNK	_	NNP	11	_	_	_	_	_	_	_	O
7	events	_	event	_	NNS	11	_	_	_	_	_	_	_	O
8	and	_	and	_	CC	11	_	_	_	_	_	_	_	O
9	mortality	_	mortality	_	NN	11	_	_	_	_	_	_	_	O
10	was	_	be	_	VBD	11	_	_	_	_	_	_	_	O
11	higher	_	higher	_	RBR	11	_	_	_	_	_	_	_	O
12	in	_	in	_	IN	11	_	_	_	_	_	_	_	O
13	poor	_	poor	_	JJ	11	_	_	_	_	_	_	_	O
14	versus	_	UNK	_	NN	11	_	_	_	_	_	_	_	O
15	good	_	good	_	JJ	11	_	_	_	_	_	good.a	Expertise	O
16	unk	_	UNK	_	NNS	11	_	_	_	_	_	_	_	O
17	.	_	.	_	.	11	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	12	_	_	_	_	_	different.a	Identicality	O
2	analytical	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
3	methods	_	method	_	NNS	12	_	_	_	_	_	_	_	O
4	that	_	that	_	WDT	12	_	_	_	_	_	_	_	O
5	took	_	take	_	VBD	12	_	_	_	_	_	_	_	O
6	into	_	into	_	IN	12	_	_	_	_	_	_	_	O
7	account	_	account	_	NN	12	_	_	_	_	_	_	_	O
8	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
10	adherence	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
12	confounding	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
13	at	_	at	_	IN	12	_	_	_	_	_	_	_	O
14	baseline	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
15	did	_	do	_	VBD	12	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	12	_	_	_	_	_	_	_	O
17	appreciably	_	UNK	_	RB	12	_	_	_	_	_	_	_	O
18	affect	_	affect	_	VB	12	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
20	results	_	result	_	NNS	12	_	_	_	_	_	_	_	O
21	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	12	_	_	_	_	_	_	_	O
2	analytical	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
3	methods	_	method	_	NNS	12	_	_	_	_	_	method.n	Means	O
4	that	_	that	_	WDT	12	_	_	_	_	_	_	_	O
5	took	_	take	_	VBD	12	_	_	_	_	_	_	_	O
6	into	_	into	_	IN	12	_	_	_	_	_	_	_	O
7	account	_	account	_	NN	12	_	_	_	_	_	_	_	O
8	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
10	adherence	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
12	confounding	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
13	at	_	at	_	IN	12	_	_	_	_	_	_	_	O
14	baseline	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
15	did	_	do	_	VBD	12	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	12	_	_	_	_	_	_	_	O
17	appreciably	_	UNK	_	RB	12	_	_	_	_	_	_	_	O
18	affect	_	affect	_	VB	12	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
20	results	_	result	_	NNS	12	_	_	_	_	_	_	_	O
21	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	12	_	_	_	_	_	_	_	O
2	analytical	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
3	methods	_	method	_	NNS	12	_	_	_	_	_	_	_	O
4	that	_	that	_	WDT	12	_	_	_	_	_	that.adv	Degree	O
5	took	_	take	_	VBD	12	_	_	_	_	_	_	_	O
6	into	_	into	_	IN	12	_	_	_	_	_	_	_	O
7	account	_	account	_	NN	12	_	_	_	_	_	_	_	O
8	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
10	adherence	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
12	confounding	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
13	at	_	at	_	IN	12	_	_	_	_	_	_	_	O
14	baseline	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
15	did	_	do	_	VBD	12	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	12	_	_	_	_	_	_	_	O
17	appreciably	_	UNK	_	RB	12	_	_	_	_	_	_	_	O
18	affect	_	affect	_	VB	12	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
20	results	_	result	_	NNS	12	_	_	_	_	_	_	_	O
21	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	12	_	_	_	_	_	_	_	O
2	analytical	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
3	methods	_	method	_	NNS	12	_	_	_	_	_	_	_	O
4	that	_	that	_	WDT	12	_	_	_	_	_	_	_	O
5	took	_	take	_	VBD	12	_	_	_	_	_	take.v	Ride_vehicle	O
6	into	_	into	_	IN	12	_	_	_	_	_	_	_	O
7	account	_	account	_	NN	12	_	_	_	_	_	_	_	O
8	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
10	adherence	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
12	confounding	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
13	at	_	at	_	IN	12	_	_	_	_	_	_	_	O
14	baseline	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
15	did	_	do	_	VBD	12	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	12	_	_	_	_	_	_	_	O
17	appreciably	_	UNK	_	RB	12	_	_	_	_	_	_	_	O
18	affect	_	affect	_	VB	12	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
20	results	_	result	_	NNS	12	_	_	_	_	_	_	_	O
21	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	12	_	_	_	_	_	_	_	O
2	analytical	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
3	methods	_	method	_	NNS	12	_	_	_	_	_	_	_	O
4	that	_	that	_	WDT	12	_	_	_	_	_	_	_	O
5	took	_	take	_	VBD	12	_	_	_	_	_	_	_	O
6	into	_	into	_	IN	12	_	_	_	_	_	_	_	O
7	account	_	account	_	NN	12	_	_	_	_	_	account.n	Explaining_the_facts	O
8	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
10	adherence	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
12	confounding	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
13	at	_	at	_	IN	12	_	_	_	_	_	_	_	O
14	baseline	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
15	did	_	do	_	VBD	12	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	12	_	_	_	_	_	_	_	O
17	appreciably	_	UNK	_	RB	12	_	_	_	_	_	_	_	O
18	affect	_	affect	_	VB	12	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
20	results	_	result	_	NNS	12	_	_	_	_	_	_	_	O
21	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	12	_	_	_	_	_	_	_	O
2	analytical	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
3	methods	_	method	_	NNS	12	_	_	_	_	_	_	_	O
4	that	_	that	_	WDT	12	_	_	_	_	_	_	_	O
5	took	_	take	_	VBD	12	_	_	_	_	_	_	_	O
6	into	_	into	_	IN	12	_	_	_	_	_	_	_	O
7	account	_	account	_	NN	12	_	_	_	_	_	_	_	O
8	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
10	adherence	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
12	confounding	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
13	at	_	at	_	IN	12	_	_	_	_	_	_	_	O
14	baseline	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
15	did	_	do	_	VBD	12	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	12	_	_	_	_	_	not.adv	Negation	O
17	appreciably	_	UNK	_	RB	12	_	_	_	_	_	_	_	O
18	affect	_	affect	_	VB	12	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
20	results	_	result	_	NNS	12	_	_	_	_	_	_	_	O
21	.	_	.	_	.	12	_	_	_	_	_	_	_	O

1	different	_	Different	_	NNP	12	_	_	_	_	_	_	_	O
2	analytical	_	UNK	_	JJ	12	_	_	_	_	_	_	_	O
3	methods	_	method	_	NNS	12	_	_	_	_	_	_	_	O
4	that	_	that	_	WDT	12	_	_	_	_	_	_	_	O
5	took	_	take	_	VBD	12	_	_	_	_	_	_	_	O
6	into	_	into	_	IN	12	_	_	_	_	_	_	_	O
7	account	_	account	_	NN	12	_	_	_	_	_	_	_	O
8	changes	_	change	_	NNS	12	_	_	_	_	_	_	_	O
9	in	_	in	_	IN	12	_	_	_	_	_	_	_	O
10	adherence	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
11	and	_	and	_	CC	12	_	_	_	_	_	_	_	O
12	confounding	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
13	at	_	at	_	IN	12	_	_	_	_	_	_	_	O
14	baseline	_	UNK	_	NN	12	_	_	_	_	_	_	_	O
15	did	_	do	_	VBD	12	_	_	_	_	_	_	_	O
16	not	_	not	_	RB	12	_	_	_	_	_	_	_	O
17	appreciably	_	UNK	_	RB	12	_	_	_	_	_	_	_	O
18	affect	_	affect	_	VB	12	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	12	_	_	_	_	_	_	_	O
20	results	_	result	_	NNS	12	_	_	_	_	_	result.n	Earnings_and_losses	O
21	.	_	.	_	.	12	_	_	_	_	_	_	_	O

